Emergent BioSolutions | EBS - EPS Earnings Per Share


Emergent BioSolutions reported $-0.77 in EPS Earnings Per Share for its fiscal quarter ending in December of 2023.





Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Akebia Therapeutics USD 0.03 0.13 Mar/2025
ALKERMES USD 0.29 0.2 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amarin USD 0.08 0.11 Sep/2025
ANI Pharmaceuticals USD 2.33 0.29 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Coherus Biosciences USD -0.35 0.07 Mar/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Exact Sciences USD -0.45 0.69 Dec/2025
Exelixis USD 0.97 0.19 Dec/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
Heron Therapeutics USD -0.03 0.03 Sep/2024
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Ironwood Pharmaceuticals USD -0.01 0.25 Dec/2025
Lexicon Pharmaceuticals USD -0.17 0.02 Jun/2024
Lonza CHF 6.07 1.92 Jun/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Myriad Genetics USD 0.04 0.01 Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Pacira USD 0.06 0.64 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
United Therapeutics USD 7.7 0.54 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Xoma USD -1.59 2.43 Sep/2024